fbpx

Lifecore Biomedical Inc

LFCR

$7.19

Closing

▼-5.52%

1D

▲16.16%

YTD

LFCR

BBG001S7VTL0

Exchange

Sector

Market cap

$264.79M

Volume

36,649

Check if the stock is halal

Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.

We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.

Get started from just $6.99/month

Market cap

$264.79M

Analysts' Rating

HOLD

Price Target (Mean)

5.00

Total Analysts

1

P/E

194.64

Operating Margin

5.67%

Beta

1.00

Revenue Growth

21.64%

52 week high

$8.62

52 week low

$3.68

Div. Yield

%

EPS Growth

0.00

Company Profile

Lifecore Biomedical, Inc. is a fully integrated contract development and manufacturing organization (CDMO). The Company designs, develops, manufactures and sells differentiated products for biomaterials markets and license technology applications to partners. The Company offers highly differentiated capabilities in the development, fill and finish of sterile, injectable-grade pharmaceutical products in syringes and vials. It is involved in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a spectrum of medical conditions and procedures. The Company uses its fermentation process and aseptic formulation and filling expertise to develop HA-based products for multiple applications and to take advantage of non-HA devices and drug opportunities.